vs
Side-by-side financial comparison of TopBuild Corp (BLD) and Solventum (SOLV). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× TopBuild Corp). TopBuild Corp runs the higher net margin — 7.2% vs 0.6%, a 6.6% gap on every dollar of revenue. On growth, TopBuild Corp posted the faster year-over-year revenue change (17.2% vs -3.0%). Over the past eight quarters, TopBuild Corp's revenue compounded faster (2.9% CAGR vs -1.8%).
HashiCorp, Inc. is an American software company with a freemium business model based in San Francisco, California. HashiCorp provides tools and products that enable developers, operators and security professionals to provision, secure, run and connect cloud-computing infrastructure. It was founded in 2012 by Mitchell Hashimoto and Armon Dadgar. The company name HashiCorp is a portmanteau of co-founder last name Hashimoto and Corporation.
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
BLD vs SOLV — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $2.0B |
| Net Profit | $104.8M | $13.0M |
| Gross Margin | 27.7% | 54.7% |
| Operating Margin | 12.1% | 4.0% |
| Net Margin | 7.2% | 0.6% |
| Revenue YoY | 17.2% | -3.0% |
| Net Profit YoY | -15.1% | — |
| EPS (diluted) | $3.73 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | $2.0B | ||
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.3B | $2.2B | ||
| Q1 25 | $1.2B | $2.1B | ||
| Q4 24 | $1.3B | $2.1B | ||
| Q3 24 | $1.4B | $2.1B | ||
| Q2 24 | $1.4B | $2.1B |
| Q1 26 | $104.8M | $13.0M | ||
| Q4 25 | $104.5M | $63.0M | ||
| Q3 25 | $142.2M | $1.3B | ||
| Q2 25 | $151.6M | $90.0M | ||
| Q1 25 | $123.4M | $137.0M | ||
| Q4 24 | $150.5M | $31.0M | ||
| Q3 24 | $169.0M | $122.0M | ||
| Q2 24 | $150.7M | $89.0M |
| Q1 26 | 27.7% | 54.7% | ||
| Q4 25 | 27.2% | 51.4% | ||
| Q3 25 | 30.1% | 54.2% | ||
| Q2 25 | 30.4% | 54.4% | ||
| Q1 25 | 28.5% | 53.8% | ||
| Q4 24 | 29.9% | 53.9% | ||
| Q3 24 | 30.7% | 56.0% | ||
| Q2 24 | 31.0% | 54.6% |
| Q1 26 | 12.1% | 4.0% | ||
| Q4 25 | 12.1% | 6.3% | ||
| Q3 25 | 15.4% | 80.6% | ||
| Q2 25 | 16.9% | 9.9% | ||
| Q1 25 | 14.4% | 7.3% | ||
| Q4 24 | 16.6% | 6.6% | ||
| Q3 24 | 17.8% | 13.2% | ||
| Q2 24 | 15.4% | 11.7% |
| Q1 26 | 7.2% | 0.6% | ||
| Q4 25 | 7.0% | 3.2% | ||
| Q3 25 | 10.2% | 60.4% | ||
| Q2 25 | 11.7% | 4.2% | ||
| Q1 25 | 10.0% | 6.6% | ||
| Q4 24 | 11.5% | 1.5% | ||
| Q3 24 | 12.3% | 5.9% | ||
| Q2 24 | 11.0% | 4.3% |
| Q1 26 | $3.73 | $0.07 | ||
| Q4 25 | $3.69 | $0.37 | ||
| Q3 25 | $5.04 | $7.22 | ||
| Q2 25 | $5.32 | $0.51 | ||
| Q1 25 | $4.23 | $0.78 | ||
| Q4 24 | $5.07 | $0.18 | ||
| Q3 24 | $5.65 | $0.70 | ||
| Q2 24 | $4.78 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $268.8M | $561.0M |
| Total DebtLower is stronger | $2.8B | $4.6B |
| Stockholders' EquityBook value | $2.4B | $5.0B |
| Total Assets | $6.7B | $14.1B |
| Debt / EquityLower = less leverage | 1.18× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.8M | $561.0M | ||
| Q4 25 | $184.7M | $878.0M | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $842.5M | $492.0M | ||
| Q1 25 | $308.8M | $534.0M | ||
| Q4 24 | $400.3M | $762.0M | ||
| Q3 24 | $257.3M | $772.0M | ||
| Q2 24 | $463.2M | $897.0M |
| Q1 26 | $2.8B | $4.6B | ||
| Q4 25 | $2.8B | $5.0B | ||
| Q3 25 | $2.9B | $5.1B | ||
| Q2 25 | $1.9B | $7.8B | ||
| Q1 25 | $1.4B | $7.9B | ||
| Q4 24 | $1.4B | $8.0B | ||
| Q3 24 | $1.4B | $8.1B | ||
| Q2 24 | $1.4B | $8.3B |
| Q1 26 | $2.4B | $5.0B | ||
| Q4 25 | $2.3B | $5.0B | ||
| Q3 25 | $2.2B | $5.0B | ||
| Q2 25 | $2.1B | $3.6B | ||
| Q1 25 | $2.1B | $3.3B | ||
| Q4 24 | $2.2B | $3.0B | ||
| Q3 24 | $2.1B | $3.2B | ||
| Q2 24 | $2.4B | $2.9B |
| Q1 26 | $6.7B | $14.1B | ||
| Q4 25 | $6.6B | $14.3B | ||
| Q3 25 | $6.4B | $14.0B | ||
| Q2 25 | $5.1B | $15.1B | ||
| Q1 25 | $4.6B | $14.5B | ||
| Q4 24 | $4.7B | $14.5B | ||
| Q3 24 | $4.7B | $14.7B | ||
| Q2 24 | $4.9B | $14.6B |
| Q1 26 | 1.18× | 0.92× | ||
| Q4 25 | 1.23× | 1.00× | ||
| Q3 25 | 1.29× | 1.03× | ||
| Q2 25 | 0.88× | 2.14× | ||
| Q1 25 | 0.65× | 2.43× | ||
| Q4 24 | 0.62× | 2.71× | ||
| Q3 24 | 0.66× | 2.54× | ||
| Q2 24 | 0.59× | 2.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $160.7M | — |
| Free Cash FlowOCF − Capex | — | $-273.0M |
| FCF MarginFCF / Revenue | — | -13.6% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-203.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $160.7M | — | ||
| Q4 25 | $176.7M | $95.0M | ||
| Q3 25 | $233.3M | $76.0M | ||
| Q2 25 | $193.7M | $169.0M | ||
| Q1 25 | $152.6M | $29.0M | ||
| Q4 24 | $266.2M | $219.0M | ||
| Q3 24 | $240.7M | $169.0M | ||
| Q2 24 | $90.4M | $355.0M |
| Q1 26 | — | $-273.0M | ||
| Q4 25 | $159.4M | $32.0M | ||
| Q3 25 | $216.2M | $-21.0M | ||
| Q2 25 | $182.2M | $59.0M | ||
| Q1 25 | $139.2M | $-80.0M | ||
| Q4 24 | $253.7M | $92.0M | ||
| Q3 24 | $219.8M | $76.0M | ||
| Q2 24 | $74.3M | $297.0M |
| Q1 26 | — | -13.6% | ||
| Q4 25 | 10.7% | 1.6% | ||
| Q3 25 | 15.5% | -1.0% | ||
| Q2 25 | 14.0% | 2.7% | ||
| Q1 25 | 11.3% | -3.9% | ||
| Q4 24 | 19.3% | 4.4% | ||
| Q3 24 | 16.0% | 3.7% | ||
| Q2 24 | 5.4% | 14.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 3.2% | ||
| Q3 25 | 1.2% | 4.6% | ||
| Q2 25 | 0.9% | 5.1% | ||
| Q1 25 | 1.1% | 5.3% | ||
| Q4 24 | 1.0% | 6.1% | ||
| Q3 24 | 1.5% | 4.5% | ||
| Q2 24 | 1.2% | 2.8% |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.69× | 1.51× | ||
| Q3 25 | 1.64× | 0.06× | ||
| Q2 25 | 1.28× | 1.88× | ||
| Q1 25 | 1.24× | 0.21× | ||
| Q4 24 | 1.77× | 7.06× | ||
| Q3 24 | 1.42× | 1.39× | ||
| Q2 24 | 0.60× | 3.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLD
| Installation Services | $651.1M | 45% |
| Specialty Distribution | $562.9M | 39% |
| Other | $231.8M | 16% |
SOLV
| Infection Prevention and Surgical Solutions | $737.0M | 37% |
| Advanced Wound Care | $497.0M | 25% |
| Dental Solutions | $354.0M | 18% |
| Health Information Systems | $342.0M | 17% |
| All Other 4 | $76.0M | 4% |
